UK Companies House feature
NOVA LABORATORIES LIMITED
Profile
- Company number
- 02875110
- Status
- Active
- Incorporation
- 1993-11-25
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Moore
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “During the year, we took out a bank loan, and also used a proportion of our cash reserves, to fund a dividend of £24m which was paid to our parent company in order to facilitate a buyback of all minority shareholdings. This resulted in net assets falling from £52m in 2024 to £35m at the year end.”
- “During the year, we launched our 4th licensed product, Qaialdo, in February.”
- “During the year, we also completed the first part of new production facility, and commenced the second part this will assist us as our product portfolio expands and we move into new markets.”
- “Our 2nd automated filling line is expected to be ready for use in early 2026.”
- “Subsequent to the year end, the intercompany loan balance of £6m due to Nova Bio-Pharma Holdings Limited was fully repaid on 31 October 2025.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEISHMAN, Karen Alison | Secretary | 2024-01-01 | — | — |
| WHITE, James Andrew Pitt | Director | 2020-10-08 | Sep 1985 | British |
| WHITE, Peter John Pitt, Dr | Director | 1993-11-25 | May 1948 | British |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CUSHING, Anthony Charles | Secretary | 1993-11-25 | 1993-12-01 |
| EGGER, Patricia Janet | Secretary | 1993-12-01 | 1999-08-26 |
| JONES, Mary | Secretary | 2001-04-30 | 2002-03-31 |
| ROBINSON, Andrew Charles | Secretary | 2012-10-26 | 2016-09-16 |
| SEARY, Derek | Secretary | 1999-08-26 | 2001-04-20 |
| SEATON, John Neil | Secretary | 2002-03-31 | 2012-06-15 |
| STANIFORTH, Clement Roger | Secretary | 2016-11-23 | 2024-01-01 |
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 1993-11-25 | 1993-11-25 |
| BUMPHREY, Gillian Elizabeth | Director | 1993-12-01 | 2000-02-07 |
| DANN, Shirley Margaret | Director | 2000-02-07 | 2002-09-26 |
| EGGER, Patricia Janet | Director | 1993-12-01 | 2003-03-13 |
| HOUGHTON, Derek | Director | 1999-08-26 | 2006-10-19 |
| JONES, Allan Michael | Director | 2002-09-01 | 2003-03-27 |
| LAFFERTY, Ian William, Dr | Director | 2004-10-01 | 2009-01-06 |
| SEATON, John Neil | Director | 2003-09-04 | 2012-06-15 |
| SEDDON, Peter James | Director | 2003-04-01 | 2006-08-31 |
| THOMAS, Jeffrey Lynn, Dr | Director | 1999-11-01 | 2008-05-26 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 1993-11-25 | 1993-11-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nova Bio-Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 127 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-29 | AA | accounts | accounts with accounts type full |
| 2025-11-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-12 | AA | accounts | accounts with accounts type full |
| 2024-11-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-18 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-11-01 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-01-02 | TM02 | officers | termination secretary company with name termination date |
| 2024-01-02 | AP03 | officers | appoint person secretary company with name date |
| 2023-11-28 | AA | accounts | accounts with accounts type full |
| 2023-11-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-11-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-26 | AA | accounts | accounts with accounts type full |
| 2021-11-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-11-25 | AA | accounts | accounts with accounts type full |
| 2020-11-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-11-04 | AA | accounts | accounts with accounts type full |
| 2020-10-12 | AP01 | officers | appoint person director company with name date |
| 2019-12-04 | AA | accounts | accounts with accounts type full |
| 2019-11-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2018-11-26 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.